William Zehnder - Quipt Home Chief Relations
| QIPT Stock | USD 2.68 0.23 9.39% |
Insider
William Zehnder is Chief Relations of Quipt Home Medical
| Age | 49 |
| Address | 1019 Town Drive, Wilder, KY, United States, 41076 |
| Phone | 859 878 2220 |
| Web | https://quipthomemedical.com |
William Zehnder Latest Insider Activity
Tracking and analyzing the buying and selling activities of William Zehnder against Quipt Home stock is an integral part of due diligence when investing in Quipt Home. William Zehnder insider activity provides valuable insight into whether Quipt Home is net buyers or sellers over its current business cycle. Note, Quipt Home insiders must abide by specific rules, including filing SEC forms every time they buy or sell Quipt Home'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
William Zehnder over two months ago Disposition of 6735 shares by William Zehnder of Viemed Healthcare subject to Rule 16b-3 | ||
William Zehnder over six months ago Payment of 6667 shares by William Zehnder of Viemed Healthcare subject to Rule 16b-3 | ||
William Zehnder over six months ago Exercise or conversion by William Zehnder of 18979 shares of Viemed Healthcare subject to Rule 16b-3 |
Quipt Home Management Efficiency
The company has return on total asset (ROA) of 0.0115 % which means that it generated a profit of $0.0115 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0451) %, meaning that it created substantial loss on money invested by shareholders. Quipt Home's management efficiency ratios could be used to measure how well Quipt Home manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.02 in 2024. Return On Capital Employed is likely to drop to 0.02 in 2024. At this time, Quipt Home's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 298.7 M in 2024, whereas Change To Liabilities is likely to drop slightly above 1.5 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark CPA | Treace Medical Concepts | 54 | |
| Ehab Esmail | Orthofix Medical | 52 | |
| Scott Capps | Artivion | 53 | |
| Paul Badawi | Sight Sciences | 49 | |
| Minni Vittal | Procept Biorobotics Corp | N/A | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Jesse Selnick | Sight Sciences | N/A | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
| John Davis | Artivion | 59 | |
| Anthony Semedo | Artivion | 69 | |
| Mark Saxton | Neuropace | 59 | |
| Mark Quick | Orthofix Medical | N/A | |
| Derrick Sung | Pulmonx Corp | 51 | |
| Lee Rosenthal | Paragon 28 | N/A | |
| Antony Koblish | Tela Bio | 58 | |
| Paul Talmo | Tela Bio | 52 | |
| Jeremy Hayden | Sight Sciences | 54 | |
| Stephen Kilmer | Profound Medical Corp | N/A | |
| Geoffrey Rose | Pulmonx Corp | 50 | |
| Thomas Ackerman | Artivion | 66 | |
| Rebecca Kuhn | Neuropace | 63 | |
Management Performance
| Return On Equity | -0.0451 | ||||
| Return On Asset | 0.0115 |
Quipt Home Medical Leadership Team
Elected by the shareholders, the Quipt Home's board of directors comprises two types of representatives: Quipt Home inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quipt. The board's role is to monitor Quipt Home's management team and ensure that shareholders' interests are well served. Quipt Home's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quipt Home's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hardik Mehta, Chief Officer | ||
| William Zehnder, Chief Relations | ||
| Robert LLB, Corporate Secretary | ||
| Mark Miles, Vice Technology | ||
| William MD, Chief Officer | ||
| David Bachelder, Executive Operations | ||
| Gregory Crawford, President Chairman | ||
| Jerry Kirn, VP Operations | ||
| Cole Stevens, VP Relations | ||
| Leslie Becker, Exec Devel | ||
| Thomas Roehrig, Executive Finance | ||
| Patrick Gamble, Executive Operations |
Quipt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quipt Home a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0451 | ||||
| Return On Asset | 0.0115 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 188.77 M | ||||
| Shares Outstanding | 43.09 M | ||||
| Shares Owned By Insiders | 3.80 % | ||||
| Shares Owned By Institutions | 55.01 % | ||||
| Number Of Shares Shorted | 859.8 K | ||||
| Price To Earning | 98.25 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Quipt Stock Analysis
When running Quipt Home's price analysis, check to measure Quipt Home's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quipt Home is operating at the current time. Most of Quipt Home's value examination focuses on studying past and present price action to predict the probability of Quipt Home's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quipt Home's price. Additionally, you may evaluate how the addition of Quipt Home to your portfolios can decrease your overall portfolio volatility.